ProPhase Labs Inc (PRPH)
2.40
+0.13
(+5.73%)
USD |
NASDAQ |
Sep 27, 16:00
2.39
-0.01
(-0.42%)
Pre-Market: 20:00
ProPhase Labs Gross Profit (Quarterly): -0.476M for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -0.476M |
March 31, 2024 | -0.433M |
December 31, 2023 | -3.056M |
September 30, 2023 | 2.327M |
June 30, 2023 | 6.448M |
March 31, 2023 | 10.52M |
December 31, 2022 | 11.28M |
September 30, 2022 | 11.97M |
June 30, 2022 | 18.72M |
March 31, 2022 | 28.68M |
December 31, 2021 | 24.62M |
September 30, 2021 | 3.977M |
June 30, 2021 | 4.466M |
March 31, 2021 | 8.927M |
December 31, 2020 | 1.87M |
September 30, 2020 | 1.042M |
June 30, 2020 | 1.279M |
March 31, 2020 | 0.415M |
December 31, 2019 | 1.00M |
September 30, 2019 | 0.834M |
June 30, 2019 | 0.261M |
March 31, 2019 | 0.52M |
December 31, 2018 | 1.341M |
September 30, 2018 | 0.756M |
June 30, 2018 | 1.258M |
Date | Value |
---|---|
March 31, 2018 | 1.425M |
December 31, 2017 | 1.292M |
September 30, 2017 | 0.432M |
June 30, 2017 | 0.14M |
March 31, 2017 | 0.085M |
December 31, 2016 | 0.487M |
September 30, 2016 | 0.197M |
June 30, 2016 | 0.028M |
March 31, 2016 | 0.285M |
December 31, 2015 | -6.557M |
September 30, 2015 | 2.719M |
June 30, 2015 | 1.007M |
March 31, 2015 | 3.662M |
December 31, 2014 | 5.897M |
September 30, 2014 | 3.51M |
June 30, 2014 | 0.792M |
March 31, 2014 | 3.98M |
December 31, 2013 | 6.587M |
September 30, 2013 | 3.817M |
June 30, 2013 | 0.928M |
March 31, 2013 | 5.339M |
December 31, 2012 | 5.687M |
September 30, 2012 | 3.399M |
June 30, 2012 | 0.825M |
March 31, 2012 | 4.34M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-3.056M
Minimum
Dec 2023
28.68M
Maximum
Mar 2022
6.720M
Average
3.152M
Median
Gross Profit (Quarterly) Benchmarks
Fonar Corp | 11.75M |
XWELL Inc | 3.079M |
Applied DNA Sciences Inc | 0.2452M |
Veracyte Inc | 77.91M |
OncoCyte Corp | 0.05M |